LIPOCINE INC (LPCN)

US53630X2036 - Common Stock

6.04  +0.29 (+5.04%)

After market: 6 -0.04 (-0.66%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
4.71M-2.85M500.00K16.14M0.00
Operating Expenses
15.08M15.08M12.62M13.00M17.99M
Research and Development
9.89M10.18M8.56M7.67M9.75M
Selling, General, and Administrative Expenses
5.19M4.90M4.06M5.33M8.25M
Operating Income
-10.37M-17.93M-12.12M3.15M-17.99M
Interest Income/Expense
1.33M1.37M550.00K-140.00K-310.00K
Other Income/Expense
72.20K212.69K570.00K360.00K-2.89M
Non Recurring Items
N/A0.00250.00K-4.00M230.00K
Income Before Taxes
-8.97M-16.35M-10.76M-630.00K-20.96M
Income Tax
760.00760.000.000.000.00
Net Income
-8.97M-16.35M-10.76M-630.00K-20.96M
EBITDA
-10.33M-17.90M-12.11MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-1.71-3.10-2.06-0.12-6.40
Non GAAP EPS
-1.71-3.05-2.210.05-0.40
 
Statistics
Profit Margin
-190.28%573.60%-2152.00%-3.90%N/A
Operating Profit Margin
-220.03%628.98%-2424.00%19.52%N/A

All data in USD

Charts